Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jun 8, 2021 (5 years ago)

Ketamine HCl Injection Solution

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect Exp. Date: Incorrect BUD.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Ketamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL), Rx Only, Compounded by Prisma Health Outsourcing Facility 1071 Holland Rd. Suite 2 Simpsonville, SC 29681. NDC: 73463-0100-01

Affected NDC 73463-0100-01

Compare with the code on your package — it is the most precise check available.

Drug: Ketamine

Recalling firm
Prisma Health Outsourcing Facility
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0648-2021 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ketamine recalls

See all

Other labeling / mix-up recalls from 2021

All labeling / mix-up recalls
Class II · Moderate risk

Moxifloxacin

Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL

Terminated Labeling / mix-up Denver Solutions, LLC DBA Leiters Health NDC 71449-096-42 D-0288-2022